#ITI#Developing live attenuated avian influenza virus in ovo vaccines for poultry#FTI#
#IRE#Live attenuated vaccines can mimic natural infection and induce humoral and cellular immune response. However, the possibility of reassortment between vaccine viruses and field isolates and of mutations from low-pathogenic to highly pathogenic viruses has prevented the use of live attenuated strains as poultry vaccines. In ovo vaccination using live attenuated strains that can undergo limited replication cycles would be a better option, because these strains can be used for mass vaccination without spreading or reassorting with other viruses. Our previous study demonstrated that two influenza nonstructural (NS) variant viruses are highly attenuated and immunogenic in chickens, making them potential live vaccine candidates. In this study, we tested whether NS variants could be used as in ovo vaccines alone or in combination with temperature-sensitive (ts) mutations. In addition, we also tested the effect of different hemagglutinin (HA) subtypes on in ovo vaccination of NS variants. Our results demonstrated that NS variants alone or in combination with ts mutations were not attenuated enough to be used for in ovo vaccination. We also observed variable effects of different HA subtypes in the same NS deletion variant backbone on hatchability. However, even with substitution of HA subtypes, NS variant-inoculated eggs still had lower hatchability compared to the mock control group, indicating that the high virulence of NS variant backbone strain in eggs might have affected the results. Â© 2010 American Association of Avian Pathologists.#FRE#
#IPC#Avian influenza virus; In ovo vaccines; Live attenuated; NS variants; Ts mutations; Ts phenotype#FPC#
#IRF#Belshe R.B., Current status of live attenuated influenza virus vaccine in the US, Virus Res., 103, pp. 177-185, (2004); 
Bublot M., Pritchard N., Cruz J.S., Mickle T.R., Selleck P., Swayne D.E., Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge, Avian Dis., 51, pp. 498-500, (2007); 
Chen H., Matsuoka Y., Swayne D., Chen Q., Cox N.J., Murphy B.R., Subbarao K., Generation and characterization of a coldadapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate, Vaccine, 21, pp. 4430-4436, (2003); 
Chen Z., Santos C., Aspelund A., Gillim-Ross L., Jin H., Kemble G., Subbarao K., Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets, J. Virol., 83, pp. 65-72, (2009); 
Cox N.J., Kitame F., Kendal A.P., Maassab H.F., Naeve C., Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2), Virology, 167, pp. 554-567, (1988); 
Hickman D., Hossain M.J., Song H., Araya Y., Solorzano A., Perez D.R., An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines, J. Gen. Virol., 89, pp. 2682-2690, (2008); 
Jin H., Zhou H., Lu B., Kemble G., Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from coldadapted A/Ann Arbor/6/60, J. Virol., 78, pp. 995-998, (2004); 
Joseph T., McAuliffe J., Lu B., Vogel L., Swayne D., Jin H., Kemble G., Subbarao K., A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets, Virology, 378, pp. 123-132, (2008); 
Lee C.W., Jung K., Jadhao S.J., Suarez D.L., Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses, J. Virol. Methods., 153, pp. 22-28, (2008); 
Lee C.W., Senne D.A., Suarez D.L., Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (differentiating infected from vaccinated animals) strategy for the control of avian influenza, Vaccine, 22, pp. 3175-3181, (2004); 
Lee C.W., Suarez D.L., Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus, J. Virol. Methods, 119, pp. 151-158, (2004); 
Li S., Liu C., Klimov A., Subbarao K., Perdue M.L., Mo D., Ji Y., Woods L., Hietala S., Bryant M., Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses, J. Infect. Dis., 179, pp. 1132-1138, (1999); 
Maassab H.F., Adaptation and growth characteristics of influenza virus at 25 degrees C, Nature, 213, pp. 612-614, (1967); 
Middleton D., Bingham J., Selleck P., Lowther S., Gleeson L., Lehrbach P., Robinson S., Rodenberg J., Kumar M., Andrew M., Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks, Virology, 359, pp. 66-71, (2007); 
Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., Hughes M., Perez D.R., Donis R., Hoffmann E., Hobom G., Kawaoka Y., Generation of influenza A viruses entirely from cloned cDNAs, Proc. Natl. Acad. Sci. U. S. A., 96, pp. 9345-9350, (1999); 
Ricks C.A., Avakian A., Bryan T., Gildersleeve R., Haddad E., Ilich R., King S., Murray L., Phelps P., Poston R., Whitfill C., Williams C., In Ovo Vaccination Technology. Adv. Vet. Med., 41, pp. 495-515, (1999); 
Song H., Nieto G.R., Perez D.R., A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates, J. Virol., 81, pp. 9238-9248, (2007); 
Spackman E., Swayne D.E., Suarez D.L., Senne D.A., Pedersen J.C., Killian M.L., Pasick J., Handel K., Pillai S.P., Lee C.W., Stallknecht D., Slemons R., Ip H.S., Deliberto T., Characterization of lowpathogenicity H5N1 avian influenza viruses from North America, J. Virol., 81, pp. 11612-11619, (2007); 
Stech J., Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines, Expert Rev. Vaccines, 7, pp. 739-743, (2008); 
Swayne D.E., Beck J.R., Kinney N., Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine, Avian Dis., 44, pp. 132-137, (2000); 
Talon J., Salvatore M., O'Neill R.E., Nakaya Y., Zheng H., Muster T., Garcia-Sastre A., Palese P., Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach, Proc. Natl. Acad. Sci. U. S. A., 97, pp. 4309-4314, (2000); 
Tang Y., Lee C.W., Zhang Y., Senne D.A., Dearth R., Byrum B., Perez D.R., Suarez D.L., Saif Y.M., Isolation and characterization of H3N2 influenza A virus from turkeys, Avian Dis., 49, pp. 207-213, (2005); 
Wang L., Suarez D.L., Pantin-Jackwood M., Mibayashi M., Garcia- Sastre A., Saif Y.M., Lee C.W., Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry, Vaccine, 26, pp. 3580-3586, (2008); 
Watanabe T., Watanabe S., Kim J.H., Hatta M., Kawaoka Y., Novel approach to the development of effective H5N1 influenza A virus vaccines: Use of M2 cytoplasmic tail mutants, J. Virol., 82, pp. 2486-2492, (2008)#FRF#
